Lbiati Kaouthar bought HEPA
February 19, 2024 · Form 4 insider transaction
Lbiati Kaouthar bought 85,000 shares of Hepion Pharmaceuticals, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
85,000
Price
$0.00
Total value
N/A
InsiderLbiati Kaouthar
Role—
SecurityStock Options
Transaction codeA: Grant or award
Transaction dateFebruary 19, 2024
Filing dateFebruary 21, 2024
Shares owned after88,000
OwnershipDirect
10b5-1 planNo
AmendedNo